<DOC>
	<DOCNO>NCT03037424</DOCNO>
	<brief_summary>This pragmatic , prospective , multi-center , randomize , active-control , single-blinded , non-inferiority phase 3 trial adult cardiac surgical patient . Up 12 Canadian hospital participate , trial require 2 year patient recruitment . Twelve-hundred bleeding adult cardiac surgical patient require fibrinogen supplementation due acquire hypofibrinogenemia CPB include . Patients randomize receive equivalent dose either fibrinogen concentrate ( Octafibrin ) cryoprecipitate blood bank receives first order fibrinogen supplementation deem accordance accept clinical standard . Thereafter , patient treat accord assign group time fibrinogen supplementation order treatment period ( 24 hour termination CPB ) . No aspect care modify . The primary efficacy outcome number Allogeneic blood product ( ABP ) ( red blood cell [ RBCs ] , pool apheresis platelet , plasma ) administer first 24 hour termination CPB . Safety outcomes measure first 28 day surgery , duration participation patient trial . Comparisons intention-to-treat ( ITT ) ( primary ) per-protocol ( PP ) analysis . One interim analysis conduct 600 patient treated determine whether study terminate safety reason , demonstrate non-inferiority futility reason .</brief_summary>
	<brief_title>FIBrinogen REplenishment Surgery</brief_title>
	<detailed_description />
	<mesh_term>Afibrinogenemia</mesh_term>
	<criteria>1 . Patients undergoing cardiac surgery CPB fibrinogen supplementation order accordance accept clinical standard ( significant hemorrhage know presumed hypofibrinogenemia ) . 1 . Receipt fibrinogencontaining product , include concentrate cryoprecipitate within 24 hour surgery ( exclude patient significant blood loss surgery ) 2 . History severe allergic reaction cryoprecipitate fibrinogen concentrate 3 . Refusal fibrinogen concentrate cryoprecipitate due religious reason 4 . Fibrinogen level know &gt; 3.0 g/L within 30 minute IMP order ( eliminate risk raise patient ' fibrinogen level &gt; 4.0 g/L supplementation , upper limit normal range ) 5 . Known pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Cyroprecipitate</keyword>
	<keyword>Fibrinogen</keyword>
	<keyword>Cardiac Surgery</keyword>
</DOC>